Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2003
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/13/2003WO2003093371A1 Water-soluble fiber-reactive dyes, method for the production and use thereof
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092889A1 Process for the preparation of 2-aminopyrazine derivatives
11/13/2003WO2003092695A1 Bicyclo 4.4.0 antiviral derivatives
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003017939A3 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483933A1 Water-soluble fiber-reactive dyes, preparation thereof and use thereof
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003CN1127573C Microbiology method for making heteroaromatic carboxylic acid using microbe of alcaligenes
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127488C Compouds with growth hormone releasing properties
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003US20030208074 Reacting protected heterocyclic amines in the presence of bases and solvents, to form chemical intermeadiates used as chemokine receptor antagonists
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207886 Nitrogen compounds such as 5-nitro-2,3,6-trimethoxyquinoxaline used as photostable ultraviolet radiation filters in cosmetics and drugs; sunscreen agents
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207857 Phenyl heterocyclyl ethers
11/06/2003US20030207842 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003CA2480497A1 Substituted pyrazine derivatives
11/05/2003EP1359139A1 Terphenyl compounds bearing substituted amino groups
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1358160A1 Aminal diones as potassium channel openers
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/04/2003US6642383 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642240 Treating emesis in a mammal
11/04/2003US6642225 Diazacycloalkanedione derivatives
10/2003
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/29/2003EP1357193A1 Preparation of pyrazines
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003CN1125818C Amino acid derivatives of substituted quinexaline 2,3-dione derivatives as glutamate receptor antagonists
10/28/2003US6639033 N-oxyl radicals
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/23/2003WO2003087091A1 Novel crystal of quinoxalinedione derivative anhydride
10/23/2003WO2003087067A1 Aryl-alkyne compounds as herbicides
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086404A1 Fused quinoxaline derivatives as inhibitors of akt activity
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086401A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003086279A2 Inhibitors of akt activity
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199456 Sodium channel blockers
10/23/2003EP1494675A2 Inhibitors of akt activity
10/23/2003CA2482937A1 A novel crystal of anhydride of a quinoxalinedione derivative
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2481008A1 Aryl-alkyne compounds as herbicides
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1066022B1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
10/22/2003CN1451003A Process for the preparation of a piperazine derivative
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1125067C Crystalline antifungal polymorph
10/21/2003US6635766 Process for the preparation of arylamides of heteroaromatic carboxylic acids
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635649 Piperazinedione compounds
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 187